University of Auckland Study Sheds Light on Migraine Economic Burden Data Needs
Migraine is far more than a severe headache. It is a complex neurological condition that causes intense throbbing pain, often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. For many New Zealanders, it disrupts work, family life, and daily activities, sometimes lasting for days. Researchers at the University of Auckland have now completed a detailed review of available data sources to understand the full economic cost of migraine in Aotearoa New Zealand. Their findings reveal significant gaps that must be addressed before a comprehensive cost-of-illness study can be undertaken.
The project, led by academics in the School of Population Health and the Department of Medicine, reviewed existing New Zealand datasets alongside international literature. It identified what information is currently missing and outlined steps needed for a robust future analysis. This work sets the foundation for better understanding the true societal and healthcare costs associated with migraine across the country.
Migraine Prevalence and Impact Across New Zealand Communities
Estimates suggest that around 15 percent of New Zealand adults experience migraine, with higher rates among women at approximately 18 percent compared to 12 percent for men. These figures align with global averages but highlight the need for more localised data that captures variations by age, ethnicity, and socioeconomic status. Māori, Pacific, and Asian populations, along with those in deprived areas, often face additional barriers to diagnosis and care.
The condition affects people in their prime working years most severely. Lost productivity, healthcare visits, medication costs, and reduced quality of life all contribute to a hidden economic burden. Without precise local data, policymakers struggle to allocate resources effectively or evaluate new treatments and prevention strategies.
How University of Auckland Researchers Approached the Data Review
The team adopted a systematic approach, drawing on methods refined at the university for similar health economic studies. They examined national health surveys, primary care records, hospital data, pharmaceutical dispensing information, and other administrative datasets. International examples from countries with established migraine cost studies provided useful benchmarks for comparison.
Researchers mapped out potential cost categories, including direct medical expenses, indirect costs from absenteeism and presenteeism at work, and broader societal impacts such as caregiver burden and welfare support. This framework helped pinpoint exactly where New Zealand data falls short.
Key Data Gaps Identified in the Review
Several critical areas emerged as incomplete or unavailable. Prevalence data relies heavily on global estimates rather than repeated, representative New Zealand surveys that track changes over time. Recording of migraine in general practice and hospital settings appears significantly lower than self-reported figures, pointing to under-diagnosis and under-recording.
Ethnicity-specific information remains limited, making it difficult to understand disparities in burden or access to care. Data on productivity losses, medication adherence, and the use of non-pharmacological therapies such as supplements or complementary approaches is fragmented. Linkage between different datasets, such as primary care and hospital records, also needs improvement to avoid double-counting or missing cases.
These gaps mean any current attempt to calculate national costs would rely on assumptions and proxies that reduce accuracy and reliability.
Implications for Health Research and Higher Education in New Zealand
The findings underscore the vital role universities play in advancing health economics research. At institutions like the University of Auckland, interdisciplinary teams combining population health, medicine, and data science are uniquely positioned to lead such work. Strengthening data infrastructure through university-led collaborations with government agencies and health providers could fill these gaps.
Training the next generation of researchers in health economics, epidemiology, and data linkage techniques is equally important. The study highlights opportunities for postgraduate projects and funded research programmes that directly address national health priorities.
Broader Context: Migraine as a Public Health Priority
Migraine ranks among the leading causes of disability worldwide. In New Zealand, it affects hundreds of thousands of people, many of whom manage symptoms with limited support. Better cost data would inform decisions about funding preventive medications, specialist clinics, and workplace accommodations.
Improved understanding could also reduce stigma, encouraging more people to seek diagnosis and treatment early. This aligns with broader goals of equitable healthcare access across diverse communities.
Potential Pathways to Address the Identified Gaps
Experts recommend several practical next steps. Regular inclusion of migraine-specific questions in national health surveys would provide ongoing prevalence and impact data. Enhanced electronic health record systems with standardised coding for migraine could improve recording accuracy in primary care.
Partnerships between universities, the Health Research Council, and district health boards could support linked dataset projects. Pilot studies in specific regions might test new data collection methods before national rollout. Investment in these areas would benefit not only migraine research but also studies of other chronic conditions.
Stakeholder Perspectives and Real-World Relevance
People living with migraine often report challenges accessing affordable treatments and understanding their condition. Clinicians note knowledge gaps among healthcare providers that contribute to under-diagnosis. Policymakers require solid economic evidence to justify new initiatives.
The University of Auckland review brings these voices together by showing exactly what information is missing. It provides a clear roadmap that can guide collaborative efforts across the health and research sectors.
Future Outlook for Migraine Research in Aotearoa
With these gaps identified, New Zealand is well placed to develop a world-class cost-of-illness study tailored to local contexts. Such work could serve as a model for other countries facing similar data challenges. University researchers are eager to build on this foundation, potentially through larger grants and multi-year programmes.
Progress in this area would ultimately improve lives by supporting evidence-based decisions that reduce the burden of migraine for individuals, families, and the wider economy.
Photo by Adrien Olichon on Unsplash
Conclusion: Building Stronger Foundations Through University Research
The University of Auckland study represents an important step forward in recognising migraine as a significant health and economic issue in New Zealand. By highlighting data gaps and outlining solutions, it opens the door to more accurate, actionable insights. Continued investment in higher education research will be essential to realising these benefits and advancing health outcomes nationwide.